NCT02818816View on ClinicalTrials.gov

Preoperative Brimonidine on IOP of Patients Undergoing RALP

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 24, 2017

Study Completion Date

August 7, 2017

Conditions
Prostate Cancer
Interventions
DRUG

brimonidine tartrate 0.2%

Alpha adrenergic receptor agonist

OTHER

Carboxymethylcellulose Eye Drops

Ocular lubricants

Trial Locations (1)

Unknown

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02818816 - Preoperative Brimonidine on IOP of Patients Undergoing RALP | Biotech Hunter | Biotech Hunter